Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Dova Pharma Announces Pricing Of Initial Public Offering June 28, 2017 Investors Spooked: Celgene Plummets After Slashing Its 2020 Guidance October 25, 2017 Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit November 29, 2017
